What are UnitedHealth Group's total assets?

UnitedHealth Group (UNH) holds $312.64B in total assets, up 0.9% year over year.

How much debt does UnitedHealth Group have?

UnitedHealth Group carries $77.9B in total debt against $103.90B of shareholders' equity, a debt-to-equity ratio of 0.75.

How much cash does UnitedHealth Group have?

UnitedHealth Group holds $28.0B in cash and equivalents.

Can UnitedHealth Group cover its short-term obligations?

Its current ratio is 0.80 — current liabilities exceed current assets.

Where does UnitedHealth Group's balance sheet data come from?

Every line is extracted from UnitedHealth Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

UnitedHealth Group UNH Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$24.37B-3.7%	$25.31B-0.5%	$25.43B+8.8%	$23.37B+9.3%
Short-term investments	$3.76B-1.2%	$3.8B-9.5%	$4.2B-7.6%	$4.55B+79.5%
Accounts receivable, net	$23.02B+2.9%	$22.37B+5.1%	$21.28B+20.3%	$17.68B+24.4%
Prepaid expenses and other current assets	$9.75B+18.7%	$8.21B+35.0%	$6.08B-8.1%	$6.62B+24.5%
Trading assets	——	——	——	——
Total current assets	$90.58B+5.6%	$85.78B+9.4%	$78.44B+13.6%	$69.07B+11.8%
Property and equipment, net	$10.76B+2.0%	$10.55B-7.8%	$11.45B+13.1%	$10.13B+12.9%
Goodwill	$110.5B+3.5%	$106.73B+2.9%	$103.73B+11.1%	$93.35B+23.2%
Intangible assets, net	$20.47B-12.0%	$23.27B+53.1%	$15.19B+5.5%	$14.4B+43.4%
Deferred tax assets	$2.42B-33.1%	$3.62B+19.8%	$3.02B+9.1%	$2.77B-15.2%
Other non-current assets	$23.01B+17.5%	$19.59B+13.3%	$17.3B+15.1%	$15.03B+20.0%
Equity method investments	$3.3B-93.7%	$52.35B+10.0%	$47.61B+8.9%	$43.73B+1.4%
Total investment securities	$48.67B+2.6%	$47.43B+4.3%	$45.49B+5.8%	$43B+5.2%
Available-for-sale securities	——	——	——	——
Held-to-maturity securities	$490M-4.3%	$512M-15.1%	$603M-13.4%	$696M+8.6%
Gross loans	$882M—	——	——	——
Equity securities	$2.17B+11.4%	$1.95B-23.7%	$2.55B+18.9%	$2.15B-1.3%
Total assets	$309.58B+3.8%	$298.28B+9.0%	$273.72B+11.4%	$245.71B+15.8%
Accounts payable	$38.03B+10.8%	$34.34B+7.4%	$31.96B+15.3%	$27.72B+12.5%
Accrued expenses	$28.05B+2.6%	$27.35B+1.0%	$27.07B+3.0%	$26.28B+14.4%
Deferred revenue	$3.41B+2.9%	$3.32B-1.1%	$3.36B+9.1%	$3.08B+19.6%
Current portion of long-term debt	$6.07B+33.5%	$4.55B+6.3%	$4.27B+37.4%	$3.11B-14.1%
Liabilities held for sale	——	——	——	——
Total current liabilities	$114.9B+10.7%	$103.77B+4.8%	$99.05B+11.0%	$89.24B+14.0%
Long-term debt	$72.32B-0.1%	$72.36B+24.2%	$58.26B+6.9%	$54.51B+28.6%
Other non-current liabilities	$18.25B+14.5%	$15.94B+10.2%	$14.46B+12.6%	$12.84B+8.9%
Reserve for insurance claims	$26.7B-22.0%	$34.22B+5.6%	$32.4B+11.5%	$29.06B+18.7%
Total liabilities	$207.88B+6.2%	$195.69B+11.9%	$174.8B+9.7%	$159.36B+17.4%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	3B+33,233%	9M0.0%	9M0.0%	9M-99.7%
Additional paid-in capital	$559M—	$0—	$0—	——
Retained earnings	$95.6B-0.5%	$96.04B+0.3%	$95.77B+11.2%	$86.16B+11.7%
Accumulated other comprehensive income (loss)	-$2.06B+39.1%	-$3.39B+51.8%	-$7.03B+16.3%	-$8.39B-55.9%
Redeemable noncontrolling interests	$1.61B-62.8%	$4.32B-3.9%	$4.5B-8.1%	$4.9B+241%
Noncontrolling interests	$5.98B+6.6%	$5.61B-1.0%	$5.67B+54.0%	$3.68B+12.0%
Total stockholders' equity	$100.09B+1.9%	$98.27B+4.1%	$94.42B+15.9%	$81.45B+8.5%
Total liabilities and stockholders' equity	$309.58B+3.8%	$298.28B+9.0%	$273.72B+11.4%	$245.71B+15.8%
Available-for-Sale Debt Securities - Amortized Cost	——	——	——	$46.62B+15.7%
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)	——	——	——	——
Available-for-Sale Debt Securities - Fair Value (Maturing Within 1 Year)	——	——	——	——
Cash, Cash Equivalents, and Marketable Securities	$48.18B+2.7%	$46.92B+4.5%	$44.9B+6.1%	$42.32B+5.2%
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)	$29.7B+13.8%	$26.09B+47.4%	$17.69B+38.6%	$12.77B-7.9%
Debt Securities Amortized Cost	$50.07B-0.5%	$50.33B+4.7%	$48.05B+3.1%	$46.62B—
Other Receivables	$29.7B+13.8%	$26.09B+47.4%	$17.69B+38.6%	$12.77B-7.9%
Trading Securities in Marketable Securities	$3.3B—	——	——	——
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)	——	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$23.01B+17.5%	$19.59B+13.3%	$17.3B+15.1%	$15.03B+20.0%
Equity Securities (FV-NI and No Readily Determinable FV) - Cost	$5.5B+12.2%	$4.9B0.0%	$4.9B+32.4%	$3.7B+5.7%
Equity Securities Without Readily Determinable Fair Value - Cumulative Downward Adjustments	$3.3B—	——	——	——
Equity Securities Without Readily Determinable Fair Value - Cumulative Upward Adjustments	$846M—	——	——	——
Held-to-Maturity Debt Securities - Fair Value	$489M-3.7%	$508M-14.8%	$596M-12.2%	$679M+5.6%
Held-to-Maturity Debt Securities - Maturing 1 to 5 Years	——	——	——	——
Held-to-Maturity Debt Securities - Maturing 5 to 10 Years	——	——	——	——
Held-to-Maturity Debt Securities - Maturing Over 10 Years	——	——	——	——
Investments - Amortized Cost Basis	$3.3B-93.4%	$49.82B+5.0%	$47.45B+1.8%	$46.62B+15.7%
Other intangible assets—net	$20.47B-12.0%	$23.27B+53.1%	$15.19B+5.5%	$14.4B+43.4%
Investments	$54.25B+3.6%	$52.35B+10.0%	$47.61B+8.9%	$43.73B+1.4%
Other non-current assets	$23.01B+17.5%	$19.59B+13.3%	$17.3B+15.1%	$15.03B+20.0%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$3.76B-1.2%	$3.8B-9.5%	$4.2B-7.6%	$4.55B+79.5%
Software and Technology Licenses, Net	$23.01B+17.5%	$19.59B+13.3%	$17.3B+15.1%	$15.03B+20.0%
Total Equity Investments - Estimated Fair Value	$5.5B+12.2%	$4.9B0.0%	$4.9B+32.4%	$3.7B+5.7%
Accounts payable and other current liabilities (Note 11)	$38.03B+10.8%	$34.34B+7.4%	$31.96B+15.3%	$27.72B+12.5%
Deferred income	$3.41B+2.9%	$3.32B-1.1%	$3.36B+9.1%	$3.08B+19.6%
Liability for Claims and Claims Adjustment Expense	$39.34B+14.9%	$34.22B+5.6%	$32.4B+11.5%	$29.06B+18.7%
Other accrued liabilities	$28.05B+2.6%	$27.35B+1.0%	$27.07B+3.0%	$26.28B+14.4%
Debt Maturity - 1 to 5 Years	——	——	——	——
Debt Maturity - 5 to 10 Years	——	——	——	——
Debt Maturity - Over 10 Years	——	——	——	——
Common Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common Stock Shares Issued	906M-1.0%	915M-1.0%	924M-1.1%	934M-0.7%
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Cumulative Gross Losses and Impairments	$3M-25.0%	$4M-50.0%	$8M-52.9%	$17M+750%
Cumulative Gross Unrealized Gains	$2M—	$0-100%	$1M—	$0-100%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$9M0.0%	$9M0.0%	$9M0.0%	$9M-10.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Unrealized Gains on Investments	$229M+269%	$62M-53.7%	$134M+127%	$59M-92.8%
Unrealized Losses on Investments (Before Tax)	$1.63B-45.1%	$2.96B+10.0%	$2.69B-26.6%	$3.66B+1,237%
Components	$846M—	——	——	——
Cumulative Cost Basis	$49.58B-0.5%	$49.82B+5.0%	$47.45B+3.3%	$45.93B+15.8%
Deferred Revenue Timing Percentage	——	——	——	——
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$1.63B-45.1%	$2.96B+10.0%	$2.69B-26.6%	$3.66B+1,237%
Gross Unrealized Gains	$229M+269%	$62M-53.7%	$134M+127%	$59M-92.8%
Total	$49.58B-0.5%	$49.82B+5.0%	$47.45B+3.3%	$45.93B+15.8%
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One	——	——	——	——
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One	——	——	——	——
Available for sale investments	$48.18B+2.7%	$46.92B+4.5%	$44.9B+6.1%	$42.32B+5.2%
Common stock, par value (in dollars per share)	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	$3B0.0%	$3B0.0%	$3B0.0%	$3B0.0%
Common stock, shares issued (in shares)	$906M-1.0%	$915M-1.0%	$924M-1.1%	$934M-0.7%
Common Stock, Shares, Outstanding	$906M-1.0%	$915M-1.0%	$924M-1.1%	$934M-0.7%
Short-term debt and current portion of long-term debt	$6.07B+33.5%	$4.55B+6.3%	$4.27B+37.4%	$3.11B-14.1%
Debt Securities, Available-for-Sale and Held-to-Maturity, Fair Value	$48.67B+2.6%	$47.43B+4.3%	$45.49B+5.8%	$43B—
Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions	——	——	——	——
Deferred income taxes	$2.42B-33.1%	$3.62B+19.8%	$3.02B+9.1%	$2.77B-15.2%
Equity method investments (Note 11)	$3.8B0.0%	$3.8B+171%	$1.4B-6.7%	$1.5B+15.4%
Trading securities, cost	$3.3B—	——	——	——
Forward Share Repurchase Contracts - Liability Amount	——	——	——	——
Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss	$3M-25.0%	$4M-50.0%	$8M-52.9%	$17M+750%
Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain	$2M—	$0-100%	$1M—	$0-100%
5-10 years	——	——	——	——
1-5 years	——	——	——	——
After 10 years	——	——	——	——
Within 1 year	——	——	——	——
Change in medical costs payable included within businesses held for sale	——	——	——	——
Total number of security positions	——	——	——	——
Loan receivables carrying value	$8.86B—	——	——	——
Loans Receivable Fair Value Disclosure	$882M—	——	——	——
Noncontrolling interests in subsidiaries	$5.98B+6.6%	$5.61B-1.0%	$5.67B+54.0%	$3.68B+12.0%
Other Commitment	——	——	——	——
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Redeemable noncontrolling interests in subsidiaries	$1.61B-62.8%	$4.32B-3.9%	$4.5B-8.1%	$4.9B+241%
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	——	——	——	——
Proceeds from sale of loans to third-party investors	——	——	——	——
Uncommitted Receivables Facility, Amount Collected but Not Remitted	$1B—	——	——	——
Purchase Obligation	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about UnitedHealth Group.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are UnitedHealth Group's total assets?: UnitedHealth Group (UNH) holds $312.64B in total assets, up 0.9% year over year.
How much debt does UnitedHealth Group have?: UnitedHealth Group carries $77.9B in total debt against $103.90B of shareholders' equity, a debt-to-equity ratio of 0.75.
How much cash does UnitedHealth Group have?: UnitedHealth Group holds $28.0B in cash and equivalents.
Can UnitedHealth Group cover its short-term obligations?: Its current ratio is 0.80 — current liabilities exceed current assets.
Where does UnitedHealth Group's balance sheet data come from?: Every line is extracted from UnitedHealth Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.